Tina R. Juhl

Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial

Nete Tofte, Morten Lindhardt, Katarina Adamova et al. · The Lancet Diabetes & Endocrinology · 2020 · 254 citations · Full text

Medicine, Endocrinology, Nephrology +17

Beneficial impact of spironolactone in diabetic nephropathy

K. J. Schjoedt, Kasper Rossing, Tina R. Juhl et al. · Kidney International · 2005 · 236 citations · Full text

Medicine, Endocrinology, Pharmacology +13

Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy

K. J. Schjoedt, Kasper Rossing, Tina R. Juhl et al. · Kidney International · 2006 · 212 citations

Medicine, Endocrinology, Nephrology +13

Renal Effects of Aliskiren Compared With and in Combination With Irbesartan in Patients With Type 2 Diabetes, Hypertension, and Albuminuria

Frederik Persson, Peter Rossing, Henrik Reinhard et al. · Diabetes Care · 2009 · 155 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes

Frederik Persson, Peter Rossing, K. J. Schjoedt et al. · Kidney International · 2008 · 135 citations · Full text

Medicine, Endocrinology, Pharmacology +17